“New strategies are desperately needed to treat patients with antibiotic-resistant infections that often are deadly,” said NIAID Director Anthony S. Fauci, MD. “These new NIAID grants will provide funding to researchers developing unique, non-traditional therapies that could complement or even replace currently available antibiotics that are losing effectiveness.”
The monetary awards will be distributed among 24 projects across 18 academic institutions and three industrial organizations. Funding will help cover two years of research, with the possibility of a third year of funding for the projects that prove most successful.
For a complete list of NIAID funding recipients, click here.
More articles on antibiotics:
10 top patient safety issues for 2016
Naturally occurring food preservatives kill cancer, antibiotic-resistant bugs
‘We must take action now’ and 4 other thoughts on antibiotic resistance from CDC Director Dr. Tom Frieden
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.